Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Traxler

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Antibiotics|August 1, 1980
Early intermediates in the biosynthesis of ansamycins. III. Isolation and identification of further 8-deoxyansamycins of the rifamycin-typeO Ghisalba, P Traxler, H Fuhrer, et al.
The Journal of Antibiotics|September 1, 1980
Papulacandins, a new family of antibiotics with antifungal activity. Structures of papulacandins A, B, C and DP Traxler, H Fritz, H Fuhrer, et al.
The Journal of Antibiotics|December 1, 1979
Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proansamycin B-M1 and protorifamycin i-M1O Ghisalba, P Traxler, H Fuhrer, et al.
Journal of Medicinal Chemistry|March 26, 1999
Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolonesP Traxler, J Green, H Mett, et al.
Journal De Pharmacie De Belgique|March 1, 1997
Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-RP Traxler, P Furet, H Mett, et al.
Bioscience, Biotechnology, and Biochemistry|July 9, 2016
Preparation of 4-(4'-Hydroxyanilino)-5-anilinophthalimide and 4,5-Bis-(4'-hydroxyanilino)-phthalimide by Microbial HydroxylationS Weidner, K Goeke, U Trinks, et al.
Cancer Research|August 15, 1992
Benzopyranones and benzothiopyranones: a class of tyrosine protein kinase inhibitors with selectivity for the v-abl kinaseJ F Geissler, J L Roesel, T Meyer, et al.
Journal of Computer-Aided Molecular Design|December 1, 1995
Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411P Furet, G Caravatti, N Lydon, et al.
Medicinal Research Reviews|October 19, 2001
Tyrosine kinase inhibitors: from rational design to clinical trialsP Traxler, G Bold, E Buchdunger, et al.
Journal of Medicinal Chemistry|June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinaseP Traxler, U Trinks, E Buchdunger, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Antibiotics|August 1, 1980
Early intermediates in the biosynthesis of ansamycins. III. Isolation and identification of further 8-deoxyansamycins of the rifamycin-typeO Ghisalba, P Traxler, H Fuhrer, et al.
The Journal of Antibiotics|September 1, 1980
Papulacandins, a new family of antibiotics with antifungal activity. Structures of papulacandins A, B, C and DP Traxler, H Fritz, H Fuhrer, et al.
The Journal of Antibiotics|December 1, 1979
Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proansamycin B-M1 and protorifamycin i-M1O Ghisalba, P Traxler, H Fuhrer, et al.
Journal of Medicinal Chemistry|March 26, 1999
Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolonesP Traxler, J Green, H Mett, et al.
Journal De Pharmacie De Belgique|March 1, 1997
Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-RP Traxler, P Furet, H Mett, et al.
Bioscience, Biotechnology, and Biochemistry|July 9, 2016
Preparation of 4-(4'-Hydroxyanilino)-5-anilinophthalimide and 4,5-Bis-(4'-hydroxyanilino)-phthalimide by Microbial HydroxylationS Weidner, K Goeke, U Trinks, et al.
Cancer Research|August 15, 1992
Benzopyranones and benzothiopyranones: a class of tyrosine protein kinase inhibitors with selectivity for the v-abl kinaseJ F Geissler, J L Roesel, T Meyer, et al.
Journal of Computer-Aided Molecular Design|December 1, 1995
Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411P Furet, G Caravatti, N Lydon, et al.
Medicinal Research Reviews|October 19, 2001
Tyrosine kinase inhibitors: from rational design to clinical trialsP Traxler, G Bold, E Buchdunger, et al.
Journal of Medicinal Chemistry|June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinaseP Traxler, U Trinks, E Buchdunger, et al.
Pageof 3